Skip to main content
. 2017 Sep 21;8(59):100678–100690. doi: 10.18632/oncotarget.21126

Table 1. Descriptive data of participants in the study.

Parameter Value for cohort (na)b or statistic
E (n = 50) NE (n = 50) P-value c
Age 71.86 ± 6.70 50.06 ± 7.51 0.000
T2DM [no. (%)] 24 (48) 26 (52) 0.842
Taking metformin [no. (%)] 24 (48) 26 (52) 0.842
Marital status [no. (%)]
Married 41 (82) 47 (94) 0.121
Single 1 (2) 1 (2) 1.000
Widowed 8 (16) 2 (4) 0.092
Menstrual status [no. (%)]
Premenstrual 0 (0) 19 (38) 0.000
Postmenstrual 48 (96) 28 (56) 0.000
Hysterectomy 2 (4) 3 (6) 1.000
Body mass index (kg/m2) 23.64 ± 5.15 23.49 ± 3.36 0.867
Water intake d (ml) 2453.65 ± 833.93 2445.28 ± 747.86 0.958
Events of UTIs 0.60 ± 1.36 0.34 ± 0.69 0.229
Asymptomatic bacteriuria e [no. (%)] 7 (14) 2 (4) 0.160
Urine pH 5.83 ± 0.68 5.94 ± 0.58 0.386
Urine glucose POS [no. (%)] 5 (10) 6 (12) 1.000

an, no. of subjects; bMean ± SD or no.(%); cPearson’s chi-square and Fisher’s exact tests were used with categorical variables. Independent t-test was used with continuous variables, P < 0.05 was considered statistically significant; d The amount of water intake included drinking water intake and dietary fluid intake, which was examined by the Chinese Food Frequency Questionnaire; e Asymptomatic bacteriuria was defined according to whether the cultures tested positive for E. coli (no tested positive for other bacteria in the present study), which was with greater than 105 colony forming units /mL of E. coli.